| SDG 3 – Good Health and Well-being |
national institutes of health stroke scale score, international association for the study of lung cancer, stroke thrombectomy, functional assessment of cancer therapy, european prospective investigation into cancer, sustained virological response (svr), alcohol use disorders identification test, diabetes mellitus, type 2, breast cancer resistance protein, adolescents with type 1 diabetes, national cancer database, hiv/hcv, kaposi's sarcoma-associated herpesvirus, barcelona clinic liver cancer, european prospective investigation into cancer and nutrition, distant metastasis-free survival, breast cancer resistance, oropharyngeal squamous cell carcinoma, mda-mb-231 breast cancer cells, metastatic renal cell carcinoma (mrcc), european organisation for research and treatment of cancer, incident diabetes, high-risk prostate cancer, plasma hiv-1 rna, biochemical failure, metastatic colorectal cancer (mcrc), pathologic complete response (pcr), national institutes of health stroke scale (nihss), chemoradiotherapy (crt), national institute of health stroke scale, prostate-specific membrane antigen (psma), metastatic castration-resistant prostate cancer (mcrpc), pandemic influenza a, colorectal cancer (crc) screening, mda-mb-231 breast cancer cell, chronic hepatitis c (chc), metastatic crc, health services accessibility, non??small cell lung, pandemic h1n1, hbv genotype, non??small cell, cancer and nutrition, sentinel lymph node biopsy (slnb), disease-specific survival (dss), 2009 pandemic, substance-related disorder, asthma control test, hcc recurrence, international prognostic index, substance-related disorders, mcrpc, non??small cell lung cancer, a549 lung cancer, tumor-node-metastasis, her2 status, sln biopsy, stroke center, global initiative for chronic obstructive lung disease, hcv treatment, non-muscle-invasive, advanced hepatocellular carcinoma (hcc), hcv genotype 1, neuroblastoma sh-sy5y cell, nsclcs, hiv-uninfected, cancer cell apoptosis, hiv-1 subtype, peripheral artery disease (pad), pdm09, adults with type 2 diabetes, metastatic breast cancer (mbc), epidermal growth factor receptor (egfr) mutation, cancer-specific mortality, papillary thyroid cancer (ptc), weekly paclitaxel, neuroblastoma sh-sy5y, egfr tyrosine kinase inhibitors, shiga toxin-producing escherichia coli, uncontrolled asthma, prostate cancer radiotherapy, diabetes status, opscc, european society for medical oncology, neuroblastoma sh-sy5y cells, baseline hba1c, asthma outcome, a549 lung cancer cell, neoadjuvant chemoradiation, substance use treatment, chronic hepatitis c virus (hcv) infection, cancer-related fatigue, hbv dna level, stroke thrombolysis, head and neck cancer (hnc), nmibc, acute ischemic stroke patients, diabetes medication, hiv-rna, anthracycline-based, a(h1n1)pdm09, follicular lymphoma (fl), neoadjuvant chemotherapy (nac), anaplastic lymphoma kinase (alk), crc risk, interferon and ribavirin, trail-induced apoptosis, cancer stem-like cells, tuberculin skin test (tst), cancer stem-like, cancer stem-like cell, clear cell rcc, childhood cancer survivors, exposure to pm2.5, egfr tk, asthma phenotype, slnb, marginal zone lymphoma, msi-h, pediatric obesity, mantle cell lymphoma (mcl), differentiated thyroid cancer (dtc), risk of ischemic stroke, sustained virologic response (svr), metastatic nsclc, concurrent chemoradiation, egfr tki, shiga toxin-producing escherichia coli (stec), stroke outcomes, and end results database, ca-mrsa, sustained virologic response, metastatic castration-resistant prostate cancer, health services access, asthma outcomes, latent tuberculosis infection (ltbi), pharyngeal squamous cell carcinoma, hiv-infected adults, ckd stages, egfr-tkis, surveillance, epidemiology, and end results database, cvd events, hcv therapy, end results database, breast cancer mcf-7, national cancer data base, direct-acting antivirals, national comprehensive cancer network, chronic thromboembolic pulmonary hypertension (cteph), milan criteria, crc screening, l858r, prostate cancer diagnosis, hiv/sti, chb patients, anticancer efficacy, childhood cancer survivor, hiv acquisition, prevention of mother-to-child transmission, children with type 1 diabetes, significant prostate cancer, cancer targeted, latent tuberculosis infection, hiv prevention intervention, kaposi's sarcoma-associated herpesvirus (kshv), locally advanced rectal cancer, genotype 1b, stroke registry, sentinel nodes, peritoneal cancer, metastatic castration-resistant, escherichia coli (stec), her2 expression, transarterial chemoembolization (tace), hiv-exposed, improving global outcomes, hiv-1 subtypes, lymph node ratio, asthma diagnosis, castration-resistant prostate cancer (crpc), hiv-1 integrase, brca1/2 mutation, end-stage kidney disease (eskd), obstructive cad, prostate cancer (pc), b-cell lymphoma-2, folfiri, diabetic kidney disease (dkd), mucosa-associated lymphoid tissue lymphoma, cancer pain relief, chronic hepatitis c patients, colorectal cancer risk, combination antiretroviral therapy (cart), human prostate cancer cells, pathological complete response (pcr), tki treatment, ln metastasis, pm2.5 exposure, incident stroke, cryptogenic stroke, recurrent ovarian cancer, crc cell lines, sentinel lymph node (sln), sustained viral response, hodgkin lymphoma (hl), adjuvant chemoradiation, tki therapy, hormone receptor-positive, hbv dna levels |
